Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04384055 · ClinicalTrials.gov registry record
Predicting Outcomes for Covid-19 Using Sonography
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 165
- Enrollment target
NCT04384055: Completed study, sponsored by Stanford University.
NCT04384055 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 165 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04384055 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early in the disease course.
Interventions
- DIAGNOSTIC_TEST Lung Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2020-03-21 |
| Est. Completion | 2021-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04384055
The ClinicalTrials.gov registry entry for NCT04384055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lung Ultrasound is the first listed.
NCT04384055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04384055 about?
NCT04384055 is a clinical study titled "Predicting Outcomes for Covid-19 Using Sonography". This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for healthcare workers who seek to identify Covid-19 pneumonia or patients at risk for deterioration early ...
What is the current status of trial NCT04384055?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2020-03-21. Estimated completion is 2021-11-15.
What interventions are being tested in trial NCT04384055?
The interventions under investigation include: Lung Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04384055?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.